Literature DB >> 15082497

Platelet and endothelial activation are requisites for the development of antiphospholipid syndrome.

E del Río García, C Rodríguez, J Rodríguez-Martorell, A Serrano, J A Girón-González.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15082497      PMCID： PMC1755007          DOI： 10.1136/ard.2003.010694

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  3 in total

1.  Endothelial dysfunction in patients with antiphospholipid syndrome assessed with positron emission tomography.

Authors:  Erick Alexanderson; Patricio Cruz; Angélica Vargas; Aloha Meave; Alejandro Ricalde; Jose A Talayero; José Luis Romero-Ibarra; Tovë M Goldson; Olga L Vera-Lastra; Gabriela Medina; Luis Jara; Mary-Carmen Amigo
Journal:  J Nucl Cardiol       Date:  2007-07-02       Impact factor: 5.952

2.  Prevalence and Clinical Associations of Antiphospholipid Antibodies in Systemic Sclerosis: New Data From a French Cross-Sectional Study, Systematic Review, and Meta-Analysis.

Authors:  Vincent Sobanski; Angélique Lemaire-Olivier; Jonathan Giovannelli; Luc Dauchet; Myriam Simon; Benjamin Lopez; Cécile Yelnik; Marc Lambert; Pierre-Yves Hatron; Eric Hachulla; Sylvain Dubucquoi; David Launay
Journal:  Front Immunol       Date:  2018-11-02       Impact factor: 7.561

3.  Genome-wide significant results identified for plasma apolipoprotein H levels in middle-aged and older adults.

Authors:  Karen A Mather; Anbupalam Thalamuthu; Christopher Oldmeadow; Fei Song; Nicola J Armstrong; Anne Poljak; Elizabeth G Holliday; Mark McEvoy; John B Kwok; Amelia A Assareh; Simone Reppermund; Nicole A Kochan; Teresa Lee; David Ames; Margaret J Wright; Julian N Trollor; Peter W Schofield; Henry Brodaty; Rodney J Scott; Peter R Schofield; John R Attia; Perminder S Sachdev
Journal:  Sci Rep       Date:  2016-03-31       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.